HEADER SIGNALING PROTEIN 20-OCT-17 6BD2 TITLE COMPLEX OF 14-3-3 THETA WITH AN IRSP53 PEPTIDE DOUBLY-PHOSPHORYLATED TITLE 2 AT T340 AND S366 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 14-3-3 PROTEIN THETA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 14-3-3 PROTEIN T-CELL,14-3-3 PROTEIN TAU,PROTEIN HS1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INSULIN RECEPTOR SUBSTRATE PROTEIN OF 53 KDA, PEPTIDE COMPND 8 (IRSP53); COMPND 9 CHAIN: C; COMPND 10 SYNONYM: PROTEIN BAP2,FAS LIGAND-ASSOCIATED FACTOR 3,FLAF3,INSULIN COMPND 11 RECEPTOR SUBSTRATE P53/P58,IRSP53/58,INSULIN RECEPTOR SUBSTRATE COMPND 12 PROTEIN OF 53 KDA,INSULIN RECEPTOR SUBSTRATE P53; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YWHAQ; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PTYB11; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606 KEYWDS PHOSPHATE BINDING PROTEIN, PROTEIN COMPLEX, CYTOSKELETON REGULATION, KEYWDS 2 CELL MOTILITY, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.J.KAST,R.DOMINGUEZ REVDAT 4 04-OCT-23 6BD2 1 REMARK REVDAT 3 27-NOV-19 6BD2 1 REMARK REVDAT 2 08-MAY-19 6BD2 1 JRNL REVDAT 1 24-OCT-18 6BD2 0 JRNL AUTH D.J.KAST,R.DOMINGUEZ JRNL TITL MECHANISM OF IRSP53 INHIBITION BY 14-3-3. JRNL REF NAT COMMUN V. 10 483 2019 JRNL REFN ESSN 2041-1723 JRNL PMID 30696821 JRNL DOI 10.1038/S41467-019-08317-8 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.05 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 12042 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 599 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 60.0604 - 4.6030 1.00 3013 157 0.1962 0.2534 REMARK 3 2 4.6030 - 3.6536 1.00 2875 157 0.1870 0.2225 REMARK 3 3 3.6536 - 3.1918 0.99 2826 140 0.2299 0.2584 REMARK 3 4 3.1918 - 2.9000 0.96 2729 145 0.2642 0.3082 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.040 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3973 REMARK 3 ANGLE : 0.529 5353 REMARK 3 CHIRALITY : 0.033 604 REMARK 3 PLANARITY : 0.003 684 REMARK 3 DIHEDRAL : 14.242 2491 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BD2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1000230491. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : SEALED TUBE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.540 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : QUAZAR MX REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : APEX II CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SAINT REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12087 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 60.050 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.27800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.4 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.34400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2BR9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CACL2, 13% PEG 3350, PH 7.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.94150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.10800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.50100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.10800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.94150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.50100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 231 REMARK 465 SER A 232 REMARK 465 ALA A 233 REMARK 465 GLY A 234 REMARK 465 GLU A 235 REMARK 465 GLU A 236 REMARK 465 CYS A 237 REMARK 465 ASP A 238 REMARK 465 ALA A 239 REMARK 465 ALA A 240 REMARK 465 GLU A 241 REMARK 465 GLY A 242 REMARK 465 ALA A 243 REMARK 465 GLU A 244 REMARK 465 ASN A 245 REMARK 465 ASP B 231 REMARK 465 SER B 232 REMARK 465 ALA B 233 REMARK 465 GLY B 234 REMARK 465 GLU B 235 REMARK 465 GLU B 236 REMARK 465 CYS B 237 REMARK 465 ASP B 238 REMARK 465 ALA B 239 REMARK 465 ALA B 240 REMARK 465 GLU B 241 REMARK 465 GLY B 242 REMARK 465 ALA B 243 REMARK 465 GLU B 244 REMARK 465 ASN B 245 REMARK 465 ASP C 335 REMARK 465 LYS C 345 REMARK 465 SER C 346 REMARK 465 VAL C 347 REMARK 465 THR C 348 REMARK 465 PRO C 349 REMARK 465 LYS C 350 REMARK 465 ASN C 351 REMARK 465 SER C 352 REMARK 465 TYR C 353 REMARK 465 ALA C 354 REMARK 465 THR C 355 REMARK 465 THR C 356 REMARK 465 GLU C 357 REMARK 465 ASN C 358 REMARK 465 LYS C 359 REMARK 465 THR C 360 REMARK 465 LEU C 361 REMARK 465 GLY C 370 REMARK 465 LEU C 371 REMARK 465 GLU C 372 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR B 104 -59.79 -123.25 REMARK 500 ASN B 108 43.06 -107.12 REMARK 500 LEU C 341 -71.57 -60.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1PE B 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PG4 B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PGE B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 303 DBREF 6BD2 A 1 245 UNP P27348 1433T_HUMAN 1 245 DBREF 6BD2 B 1 245 UNP P27348 1433T_HUMAN 1 245 DBREF 6BD2 C 335 372 UNP Q9UQB8 BAIP2_HUMAN 335 372 SEQRES 1 A 245 MET GLU LYS THR GLU LEU ILE GLN LYS ALA LYS LEU ALA SEQRES 2 A 245 GLU GLN ALA GLU ARG TYR ASP ASP MET ALA THR CYS MET SEQRES 3 A 245 LYS ALA VAL THR GLU GLN GLY ALA GLU LEU SER ASN GLU SEQRES 4 A 245 GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN VAL VAL SEQRES 5 A 245 GLY GLY ARG ARG SER ALA TRP ARG VAL ILE SER SER ILE SEQRES 6 A 245 GLU GLN LYS THR ASP THR SER ASP LYS LYS LEU GLN LEU SEQRES 7 A 245 ILE LYS ASP TYR ARG GLU LYS VAL GLU SER GLU LEU ARG SEQRES 8 A 245 SER ILE CYS THR THR VAL LEU GLU LEU LEU ASP LYS TYR SEQRES 9 A 245 LEU ILE ALA ASN ALA THR ASN PRO GLU SER LYS VAL PHE SEQRES 10 A 245 TYR LEU LYS MET LYS GLY ASP TYR PHE ARG TYR LEU ALA SEQRES 11 A 245 GLU VAL ALA CYS GLY ASP ASP ARG LYS GLN THR ILE ASP SEQRES 12 A 245 ASN SER GLN GLY ALA TYR GLN GLU ALA PHE ASP ILE SER SEQRES 13 A 245 LYS LYS GLU MET GLN PRO THR HIS PRO ILE ARG LEU GLY SEQRES 14 A 245 LEU ALA LEU ASN PHE SER VAL PHE TYR TYR GLU ILE LEU SEQRES 15 A 245 ASN ASN PRO GLU LEU ALA CYS THR LEU ALA LYS THR ALA SEQRES 16 A 245 PHE ASP GLU ALA ILE ALA GLU LEU ASP THR LEU ASN GLU SEQRES 17 A 245 ASP SER TYR LYS ASP SER THR LEU ILE MET GLN LEU LEU SEQRES 18 A 245 ARG ASP ASN LEU THR LEU TRP THR SER ASP SER ALA GLY SEQRES 19 A 245 GLU GLU CYS ASP ALA ALA GLU GLY ALA GLU ASN SEQRES 1 B 245 MET GLU LYS THR GLU LEU ILE GLN LYS ALA LYS LEU ALA SEQRES 2 B 245 GLU GLN ALA GLU ARG TYR ASP ASP MET ALA THR CYS MET SEQRES 3 B 245 LYS ALA VAL THR GLU GLN GLY ALA GLU LEU SER ASN GLU SEQRES 4 B 245 GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN VAL VAL SEQRES 5 B 245 GLY GLY ARG ARG SER ALA TRP ARG VAL ILE SER SER ILE SEQRES 6 B 245 GLU GLN LYS THR ASP THR SER ASP LYS LYS LEU GLN LEU SEQRES 7 B 245 ILE LYS ASP TYR ARG GLU LYS VAL GLU SER GLU LEU ARG SEQRES 8 B 245 SER ILE CYS THR THR VAL LEU GLU LEU LEU ASP LYS TYR SEQRES 9 B 245 LEU ILE ALA ASN ALA THR ASN PRO GLU SER LYS VAL PHE SEQRES 10 B 245 TYR LEU LYS MET LYS GLY ASP TYR PHE ARG TYR LEU ALA SEQRES 11 B 245 GLU VAL ALA CYS GLY ASP ASP ARG LYS GLN THR ILE ASP SEQRES 12 B 245 ASN SER GLN GLY ALA TYR GLN GLU ALA PHE ASP ILE SER SEQRES 13 B 245 LYS LYS GLU MET GLN PRO THR HIS PRO ILE ARG LEU GLY SEQRES 14 B 245 LEU ALA LEU ASN PHE SER VAL PHE TYR TYR GLU ILE LEU SEQRES 15 B 245 ASN ASN PRO GLU LEU ALA CYS THR LEU ALA LYS THR ALA SEQRES 16 B 245 PHE ASP GLU ALA ILE ALA GLU LEU ASP THR LEU ASN GLU SEQRES 17 B 245 ASP SER TYR LYS ASP SER THR LEU ILE MET GLN LEU LEU SEQRES 18 B 245 ARG ASP ASN LEU THR LEU TRP THR SER ASP SER ALA GLY SEQRES 19 B 245 GLU GLU CYS ASP ALA ALA GLU GLY ALA GLU ASN SEQRES 1 C 38 ASP SER TYR SER ASN TPO LEU PRO VAL ARG LYS SER VAL SEQRES 2 C 38 THR PRO LYS ASN SER TYR ALA THR THR GLU ASN LYS THR SEQRES 3 C 38 LEU PRO ARG SER SER SEP MET ALA ALA GLY LEU GLU MODRES 6BD2 TPO C 340 THR MODIFIED RESIDUE MODRES 6BD2 SEP C 366 SER MODIFIED RESIDUE HET TPO C 340 16 HET SEP C 366 13 HET PEG A 300 16 HET 1PE B 300 37 HET PG4 B 301 30 HET PGE B 302 23 HET EDO B 303 9 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM 1PE PENTAETHYLENE GLYCOL HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM PGE TRIETHYLENE GLYCOL HETNAM EDO 1,2-ETHANEDIOL HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE HETSYN 1PE PEG400 HETSYN EDO ETHYLENE GLYCOL FORMUL 3 TPO C4 H10 N O6 P FORMUL 3 SEP C3 H8 N O6 P FORMUL 4 PEG C4 H10 O3 FORMUL 5 1PE C10 H22 O6 FORMUL 6 PG4 C8 H18 O5 FORMUL 7 PGE C6 H14 O4 FORMUL 8 EDO C2 H6 O2 FORMUL 9 HOH *34(H2 O) HELIX 1 AA1 LYS A 3 GLU A 17 1 15 HELIX 2 AA2 ARG A 18 GLY A 33 1 16 HELIX 3 AA3 SER A 37 LYS A 68 1 32 HELIX 4 AA4 LYS A 75 TYR A 104 1 30 HELIX 5 AA5 TYR A 104 ALA A 109 1 6 HELIX 6 AA6 ASN A 111 GLU A 131 1 21 HELIX 7 AA7 CYS A 134 MET A 160 1 27 HELIX 8 AA8 HIS A 164 ILE A 181 1 18 HELIX 9 AA9 ASN A 184 GLU A 202 1 19 HELIX 10 AB1 LEU A 203 LEU A 206 5 4 HELIX 11 AB2 SER A 210 THR A 229 1 20 HELIX 12 AB3 GLU B 2 ALA B 16 1 15 HELIX 13 AB4 ARG B 18 GLN B 32 1 15 HELIX 14 AB5 SER B 37 GLN B 67 1 31 HELIX 15 AB6 SER B 72 TYR B 104 1 33 HELIX 16 AB7 ASN B 111 GLU B 131 1 21 HELIX 17 AB8 CYS B 134 MET B 160 1 27 HELIX 18 AB9 HIS B 164 ILE B 181 1 18 HELIX 19 AC1 ASN B 184 GLU B 202 1 19 HELIX 20 AC2 SER B 210 TRP B 228 1 19 LINK C ASN C 339 N TPO C 340 1555 1555 1.33 LINK C TPO C 340 N LEU C 341 1555 1555 1.33 LINK C SER C 365 N SEP C 366 1555 1555 1.33 LINK C SEP C 366 N MET C 367 1555 1555 1.33 SITE 1 AC1 5 THR A 4 ILE A 7 GLN A 8 LYS A 11 SITE 2 AC1 5 GLU A 40 SITE 1 AC2 5 ASP A 81 GLU A 208 LYS B 9 ASP B 21 SITE 2 AC2 5 ASP B 204 SITE 1 AC3 5 ASP B 102 LYS B 122 ASN B 144 ALA B 148 SITE 2 AC3 5 GLU B 151 SITE 1 AC4 4 GLU B 99 ASP B 102 LEU B 129 ASP B 137 SITE 1 AC5 5 GLU A 208 THR B 24 LYS B 27 GLU B 208 SITE 2 AC5 5 TYR B 211 CRYST1 69.883 75.002 100.216 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014310 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013333 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009978 0.00000